drugset / Trial / NCT06492226
Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(A), US-NovoLog®, and EU-NovoRapid®
RandomizedCrossoverDouble-blindOther
Summary
Single-dose, double-blind, randomized, three-period, three-treatment, six-sequence, crossover study to demonstrate pharmacokinetic and pharmacodynamic similarity between NKF-INS(A), US-NovoLog®, and EU-NovoRapid®
Timeline
- Start
- 2024-07-30
- Primary completion
- 2024-10-31
- Completion
- 2024-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | EU-NovoRapid® | Unknown | 0.3 iu/kg | Subcutaneous |
| Subject | NKF-INS(A) | Unknown | 0.3 iu/kg | Subcutaneous |
| Comparator | US-NovoLog® | Unknown | 0.3 iu/kg | Subcutaneous |
Indications
No indication recorded.